Epidemiology and outcome of sepsis in a tertiary-care hospital in a developing country

Epidemiology and Infection

Volumn 134, Issue 2, 2006, Pages 315-322

  Tanriover, M Durusu ^a   Guven, G S ^a   Sen, D ^a   Unal, S ^a   Uzun, O ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; GLYCOPEPTIDE; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; VANCOMYCIN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CULTURE; CANCER; COMORBIDITY; DEVELOPING COUNTRY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; HYPERTENSION; KIDNEY FAILURE; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PREDICTOR VARIABLE; RESPIRATORY DISTRESS; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS; SURVIVAL RATE; TERTIARY HEALTH CARE; TURKEY (REPUBLIC); URINALYSIS;

ADULT; AGED; DEVELOPING COUNTRIES; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; KIDNEY DISEASES; MALE; MEDICAL RECORDS; MIDDLE AGED; PROGNOSIS; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; SEPSIS; SURVIVAL ANALYSIS; TURKEY;

EID: 33244482847     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268805004978     Document Type: Article

References (25)

1. Riedemann NC, Guo RF, Ward PA. The enigma of sepsis. J Clin Invest 2003; 112: 460-467.
2. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554.
3. Levy MM, Fink MP, Marshall JC, et al. SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-1256.
4. Arpi M, Renneberg J, Andersen HK, Nielsen B, Larsen SO. Bacteremia at a Danish university hospital during a twenty-five-year period (1968-1992). Scand J Infect Dis 1995; 27: 245-251.
5. Velasco E, Byington R, Martins CSA, Schirmer M, Dias LCM, Gonçalves VMSC. Bloodstream infection surveillance in a cancer centre: A prospective look at clinical microbiology aspects. Clin Microbiol Infect 2004; 10: 542-549.
6. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med 2000; 26 (Suppl 1): S64-S74.
7. Padkin A, Goldfrad C, Brady AR, Young D, Black N, Rowan K. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003; 31: 2332-2338.
8. Opal SM. Severe sepsis and septic shock: Defining the clinical problem. Scand J Infect Dis 2003; 35: 529-534.
9. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-140.
10. McCabe WR, Jackson GG. Gram-negative bacteremia: I. Etiology and ecology. Arch Intern Med 1962; 110: 847-855.
11. Lundberg JS, Perl TM, Wiblin T, et al. Septic shock: An analysis of outcomes for patients with onset on hospital wards versus intensive care units. Crit Care Med 1988; 26: 1020-1024.
12. Sands KE, Bates DW, Lanken PN, et al. Epidemiology of sepsis syndrome in 8 academic medical centers. Academic Medical Center Consortium Sepsis Project Working Group. J Am Med Assoc 1997; 278: 234-240.
13. Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115: 529-535.
14. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, Jimenez-Jimenez FJ, Perez-Paredes C, Ortiz-Leyba C. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003; 31: 2742-2751.
15. Vazquez F, Mendoza MC, Villar MH, Perez F, Mendez FJ. Survey of bacteraemia in a Spanish hospital over a decade (1981-1990). J Hosp Infect 1994; 26: 111-121.
16. Gogos CA, Lekkou A, Papageorgiou O, Siagris D, Skoutelis A, Bassaris HP. Clinical prognostic markers in patients with severe sepsis: A prospective analysis of 139 consecutive cases. J Infect 2003; 47: 300-306.
17. Alberti C, Brun-Buisson C, Burchardi H, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002; 28: 108-121.
18. Uzun Ö, Akalin HE, Hayran M, Ünal S. Factors influencing prognosis in bacteremia due to Gram-negative organisms: Evaluation of 448 episodes in a Turkish University Hospital. Clin Infect Dis 1992; 15: 866-873.
19. Clermont G, Angus DC, Kalassian KG, et al. Reassessing the value of short-term mortality in sepsis: Comparing conventional approaches to modeling. Crit Care Med 2003; 31: 2627-2633.
20. Sundararjan V, MacIsaac C, Presneill J, Cade JF, Visvanathan K. Epidemiology of sepsis in Victoria, Australia. Crit Care Med 2005; 33: 71-80.
21. Brun-Buisson C, Meshaka P, Pinton P, Vallet B, EPISEPSIS Study Group. EPISEPSIS: A reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004; 30: 580-588.
22. Kubler A, Durek G, Zamirowska A, et al. Severe sepsis in Poland: Results of internet surveillance of 1043 cases. Med Sci Monit 2004; 10: 635-641.
23. Busund R, Koukline V, Utrobin U, Nedashkovsky E. Plasmapheresis in severe sepsis and septic shock: A prospective, randomised, controlled trial. Intensive Care Med 2002; 28: 1434-1439.
24. Topeli A, Ünal S, Hayran M, Akalin HE. Septic shock as a predictor of mortality in bacteremia caused by coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis 1997; 16: 411-416.
25. Pittet D, Thievent B, Wenzel RP, Li N, Auckenthaler R, Suter PM. Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. Am J Respir Crit Care Med 1996; 153: 684-693.